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Introduction
The NF2 tumor suppressor protein merlin is structurally related to the Protein 4.1 family of molecules and, specifically, a subgroup including ezrin, radixin and moesin (ERM proteins). Like the ERM proteins, merlin contains an N-terminal domain (NTD, residues 1-302), which is highly conserved among all members of the Protein 4.1 family and is thought to mediate interactions with the cytoplasmic tail of cell surface glycoproteins such as glycophorin C and CD44 (1) . The second half of the molecule contains a predicted α-helical domain (residues 303-478) and a unique C-terminus (CTD, residues 479-595). ERM proteins link the actin cytoskeleton to cell surface glycoproteins. Merlin can associate with polymerized actin in vitro by virtue of an amino (N-) terminal actin binding domain including residues 178-367. Merlin actin binding is not affected by natural NF2 patient mutations or alternatively spliced isoforms (2) . Phosphatidylinositol lipids have been implicated in ERM protein activation. For example, PI(4,5)P 2 enhances the ability of full-length radixin, but not its N-terminal domain, to bind the cytoplasmic tail of CD44. However, the tail of CD44 does not bind PI(4,5)P 2 , suggestive of an activating effect on full-length radixin (3) . Analysis of recombinant moesin T588D, which mimics phosphorylated moesin, suggests an auxiliary role for PI(4,5)P 2 in unmasking the C-terminal F-actin binding site.
Recent work using either unphosphorylated or T558 phosphorylated moesin purified from platelets revealed a dual requirement for T558 phosphorylation and the presence of a detergent and a phospholipid, such as PI(4,5)P 2 , for F-actin binding (4) . In support of a two-step activation process in which PI(4,5)P 2 renders moesin susceptible to C-terminal phosphorylation, transfection studies have suggested that enhanced phosphatidylinositol 4-phosphate 5-kinase activity results in enhanced phosphorylation of the C-terminal threonine (5).
Merlin is phosphorylated on both serine and threonine residues, and the phosphorylation status of merlin varies in response to growth conditions (6) . Previously, we demonstrated that PAK2 phosphorylates S518 and abolishes merlin N-term/C-term binding.
PAK2 phosphorylation impairs the ability of merlin to bind to two interacting proteins, CD44 and hepatocyte growth factor regulated tyrosine kinase substrate (HRS), both critical for merlin growth suppression (7) . In addition to phosphorylation of S518, PKA has recently been showed to phosphorylate S10 and affect actin cytoskeletion, mediating cell migration (8) . Most Recently, we show that Akt directly binds and phosphorylates merlin on residues T230 and S315, which abolishes merlin intramolecular NTD/CTD interaction and merlin binding to PIKE-L and other binding partners. Furthermore, Akt-mediated phosphorylation leads to merlin degradation by polyubiquitination (9) . Phosphorylation and PI(4,5)P 2 binding coordinately mediate the activation of ERM proteins (5, 10) . However, whether the dual regulatory machinery also controls merlin activity remains elusive. In this report, we show that the NTD of merlin directly associates with phosphatidylinositols, for which the "open" conformation is required. Moreover, Akt phosphorylation enhances the interaction between merlin and phosphatidylinositols. Akt phosphorylation blocks its pro-apoptotic activity. Interestingly, Akt phosphorylation of merlin substantially inhibits its pro-apoptotic activity and blocks its tumor suppressive activity on cell migration (11) .
Most recently, we have determined that merlin can also be sumoylated, and this process is modulated by Akt and PAK phosphorylation. Since cell density regulates merlin phopshorylation status through regulating Akt and PAK phosphorylation, merlin sumoylation is also regulated by cell density. Mapping experiments support that K76 might be the major sumoylation site.
Body
In this report, we show that we have successfully accomplished most of the work proposed. Task 1.To determine whether Akt phosphorylation on merlin regulates its conformation and subcellular localization (months1-12).
a. To determine Akt phosphorylation site on the NTD of merlin (months [1] [2] [3] b. To determine the effect of Akt phosphorylation of merlin on its intramolecular and intermolecular interaction (months [4] [5] [6] [7] [8] c. To determine whether Akt phosphorylation mediates merlin subcellular localization (months 9-12) Task 2. To determine the effect of phosphorylation and phosphatidylinositol lipids on merlin's binding activity (months 13-36).
a. To investigate whether Akt phosphorylation regulates merlin's binding activity to critical effectors essential for merlin growth suppression (months [13] [14] [15] [16] [17] [18] b. To examine whether phosphatidylinositol lipids mediate merlin's binding activity (months [19] [20] [21] [22] [23] [24] c. To determine whether Akt phosphorylation and PI (3, 4, 5) However, we have observed merlin sumoylation effect. Although the physiological significance of this observation remains elusive, our exciting preliminary study suggests that other post-translational modification on merlin might also implicate in regulating this tumor suppressor as well. In this final report, we will provide these exciting new data and ask for non-cost extension of this current project for one more year to wrap up the new findings.
Results
The main tasks of this project have been successfully executed. Two papers that report our results have been published in Nature Cell Biology (9) and Cancer Research (11) , respectively. In this report, we are presenting the follow-up novel observation on merlin sumoylation. Small ubiquitin-related modifier (SUMO) is a member of a family of ubiquitin-like proteins that regulates cellular function of a variety of proteins (12) . Although having fairly low amino acid sequence identity with ubiquitin, the SUMO enzymes exhibit similar tertiary structures. The mechanism for SUMO conjugation is analogous to that of the ubiquitin system, relying upon utilisation of E1, E2 and (potentially) E3 cascade enzymes (13) . Unlike ubiquitinylation, which leads, inter alia, to a degradative pathway, SUMO modification of target proteins is involved in nuclear protein targeting, formation of sub-nuclear complexes, regulation of transcriptional activities, and control of protein stability. For example, SUMO modification of p53 represents an additional regulator of p53 tumour repressor protein stability and may contribute to activation of the p53 response (14) .
Merlin can be sumoylated in vitro and in vivo
A short sequence containing the consensus Ψ-K-X-D/E (where lysine is the modified amino acid, Ψ is a large hydrophobic residue and X is any amino acid residue) is thought to be necessary for proteins to be sumoylated. Protein sequence analysis reveals that merlin contains numerous putative sumoylation sites. To explore whether merlin can be sumoylated in vitro, we conducted an in vitro sumoulation assay with purified His-merlin recombinant proteins. Merlin was robustly sumoylated by wild-type sumo1 but not mutated sumo1 ( Figure 1A , right panels). As a postive control, p53 is also markedly sumoylated by wild-type but not mutated sumo1 ( Figure 1A , left panels). To test whether merlin can be sumoylated in intact cells, we transfected GFP vector or GFP-merlin construct into His-sumo1 stable cells, and pulled down sumo1 with Ni2+ beads. Immunoblotting analysis demonstrated that GFP-merlin was selectively sumoylated ( Figure 1B ). Cotransfection of Myc-merlin and GFP-sumo1 also display similar results ( Figure 1C ). Hence, merlin can be sumoylated in vitro and in intact cells.
Akt phosphorylation mediates merlin sumoylation
Since Akt phosphorylates merlin provokes its polyubiquitination and degradation. It is possible that Akt phosphorylation might also regulates its sumoylation as well. To test this idea, we transfected GFP-tagged merlin wild-type, unphosphorylate mutant (T230AS315A) and phosphorylation mimetic merlin (T230DS315D) into His-sumo1 stable cells. Ni2+ beads pull-down assay supported that merlin (T230DS315D) was more robustly sumoylated as compared to wild-type control, whereas merlin (T230AS315A) was barely sumoylated (Figure 2A ). To further investigate whether Akt phosphorylates PIKE-A regulates its sumoylation, we are now cotransfecting GFP-merlin and myc-sumo1 with wild-type Akt, constitutive active Akt-CA (T308DS473D) and kinase-dead Akt-KD (K179A) into HEK 293 cells, we will immunoprecipitate merlin and monitor its sumoylation status by immunoblotting. To test whether endogenous Akt plays any role in mediating merlin sumoylation, we will pretreat GFP-merlin and Myc-sumo1 cotransfected cells with PI 3-kinase inhibitor wortmannin, LY294002, DMSO, Akt inhibitor Akt1/2 for 30 min, followed by EGF stimulation for another 10 min. The transfected merlin will be immunoprecipitated and monitored by immunoblotting with anti-Sumo1 antibody. These experiments are ongoing.
Cell density regulates merlin sumoylation
Merlin mediates contact inhibition of growth through signals from the extracellular matrix. At high cell density, merlin becomes hypophosphorylated and inhibits cell growth in response to hyaluronate (HA), a mucopolysaccharide that surrounds cells. At low cell density, merlin is phosphorylated, growth permissive, and exists in a complex with ezrin, moesin, and CD44 (2001, 15, 968) . To examine whether cell density also regulates merlin sumoylation, we cultured a few stable inducible merlin transfected schwannoma cell lines. The induced cells were grown at different densities. Immunoprecipitation with anti-merlin antibody showed that at 50% density but not 100% density, wild-type merlin ws markedly sumoylated in 5 4 cells. By contrast, control IgG failed to immunoprecipitate any detectable sumoylated merlin ( Figure 3A , right panels). Accordingly, merlin was evidently phosphorylated by Akt on S315 at low density, in alignment with Akt activation status ( Figure 3A , left panels). Interestingly, merlin L64P, an unfold mutant was unable to be sumoylated regardless of cell density. Consistently, merlin L64P S315 phosphorylation was not altered at 50% or 100% densities, fitting with Akt phosphorylation status ( Figure 3B ). On the other hand, merlin S315D, a PAK phosphorylation mimetic mutant, was strongly sumoylated at both 50% and 100% densities ( Figure 3C ). As expected, merlin was more robustly phosphorylated at S315 at 50% density than 100% density, so was Akt S473 phosphorylation ( Figure 3C , left panels). Hence, hyperphosphorylated merlin is prone to sumoylation.
Merlin K76R mutation affects its subcellular residency
Protein sequence analysis suggests that merlin contains at least 4 putative sumoylation motifs (75LKMD78; 363MKEE366; 454LKQD457; 542LKTE545) ( Figure 4A ). To determine which residue is a potential sumoylated site, we mutate each of the Lysine residues into Arginine in GFP-tagged full-length merlin and monitor its subcellular residency. As expected, wild-type merlin predominantly localized on the plasma membrane, so were K364R, K455R and K543R. However, approximately 25% of the K76R mutant not only distributed on the plasma membrane but also aggregated inside the cells ( Figure 4B and C). Therefore, K76 might be one of the major sumoylation sites on merlin. To confirm this possibility, we will cotransfect GFP-merlin K76R with myc-sumo1 into HEK293 cells, we will pretreat the cells with PI 3-kinase inhibitors or Akt inhibitors, followed by EGF stimulation. Transfected merlin will be immunoprecipitated with anti-GFP, and immunoblotted with anti-sumo1 antibody. We expect that merlin sumoylation signal will be substantially decreased, if K76 is the major sumoylation site. However, if merlin has multiple sumoylation sites, mutation of K76R alone might not significantly diminish merlin sumoylation signal. This study is actively pursuing in my laboratory.
Discussion
In this report, we show that merlin can be sumoylated in vitro and in vivo. This post-translational modification is regulated by Akt phosphorylation, as merlin unphosphoryaltion mutant by Akt displays impaired sumoylation activity, and phosphorylation mimetic mutant exhibits increased sumoylation effect. In alignment with this observation, cell density, which also regulates Akt phosphorylation status, mediates merlin sumoylation. PAK phosphorylation on S518 further escalates merlin sumoylation even at high density, indicating that Akt and PAK might synergistically regulate merlin sumoylation. The available data demonstrate that K76R mutation can alter merlin plasma membrane residency. Conceivably, K76 is, if not the only sumoylation sites, the major sumoulation reside in merlin.
To address whether endogenous merlin is sumoylated by Akt under physiology conditions, we are overexpressing or knocking down Akt in a variety of human cancer cells to investigate merlin sumoylation alteration. Moreover, we are exploring whether sumoylation of merlin regulates its tumor suppressive activity, its binding affinities to various binding partners including PIKE-L, CD44, Erzrin etc. Hopefully, in next few months, we should be able to have clear answers to these questions.
Merlin subcellular localization and growth suppression has been shown to be modulated by merlin phosphorylation (15) .
Using an antibody directed against merlin phosphorylated on S518, Kissil and colleagues demonstrated that phosphorylated merlin is mislocalized to the cytoplasm, and is not expressed at the cell membrane. In addition, merlin mutant that mimics S518 phosphorylation (S518D) cannot suppress cell growth or motility in RT4 rat schwannoma cells, and results in dramatic changes in cell morphology and actin cytoskeleton organization (16) . These results demonstrate that the S518D merlin mutation, which mimics merlin phosphorylation, impairs merlin growth and motility suppression activity. Recently, we provide further evidence showing that phosphorylation of merlin by Akt can also provoke merlin relocation and loss its growth inhibitory activity. The synergistic effect by PAK and Akt on merlin sumoylation might provide insight into how the signaling cross-talks affect merlin biological actions.
Recently, we show that Akt feeds back and robustly phosphorylates merlin on both T230 and S315 residues and unfolds merlin, leading to its polyubiquitination and degradation. Although either Akt or PAK phosphorylating merlin results in its binding to phosphatidylinositol lipids, merlin S518 phosphorylation by PAK can not provoke merlin polyubiquitination and degradation (9) . This finding suggests the unique aspect of the regulatory role of Akt in mediating merlin tumor suppressor. Nonetheless, it remains unclear whether PAK phosphorylation alone plays any role in triggering merlin sumoylation.
Key Research Accomplishments
 Two papers have been published (Nature Cell Biology and Cancer Research)  Merlin can be sumoylated in vitro and in vivo.
 Akt phosphorylation of merlin regulates its sumoylation  S518 phosphorylation increases merlin sumoylation  Cell density regulates merlin sumoylation  K76R mutation interferes merlin subcellular distribution
Reportable Outcomes
The above results and more in vivo functions of merlin sumoylation are being actively pursued in my laboratory.
Hopefully, in a few months, we will have a manuscript ready for submission.
Conclusion
Akt directly binds to and phosphorylates merlin on residues Thr 230 and Ser 315, which abolishes merlin NTD/CTD interactions and binding to merlin's effector protein PIKE-L and other binding partners. Furthermore, Akt-mediated phosphorylation leads to merlin degradation by ubiquitination. These studies demonstrate that Akt-mediated merlin phosphorylation regulates the function of merlin in the absence of an inactivating mutation. Akt phosphorylation and PI(3,4,5)P3 binding mediate the tumor suppressive activity of merlin. The extreme N-terminus of merlin directly interacts with phosphatidylinositols, for which the unfolded conformation is required. Moreover, Akt phosphorylation enhances merlin binding affinity to phosphatidylinositols. Further, Akt phosphorylation increases merlin distribution on the cell-cell contact plasma membrane and association with CD44. Akt phosphorylation of merlin blocks its pro-apoptotic action. EGF treatment and Akt phosphorylation provoke merlin to aggregate in the ruffled plasma membrane and promote cell migration. Thus, these results suggest that PI 3-kinase signaling regulates merlin's tumor suppressive activity via both Akt phosphorylation and phosphoinositol lipids binding to merlin. Furthermore, Akt also provokes merlin sumoylation through phosphorylating merlin. Whether this modificatiomn regulates merlin's tumor suppressive activity, protein stability, binding affinities to other binding partners remain the major topics in the ongoing project. A, wild-type merlin is high sumoylated at low density. Rat RT4 schwannoma cells that were stable transfected with wild-type merlin were culture at 50% and 100% density and the transfected merlin were induced by puramycin. The induced erlin was immunoprecipitated with anti-merlin antibody, and analyzed by anti-sumo1 antibody (right panels). Merlin, Akt phopshorylation status were analyzed (left panels).
B, Merlin L64P cannot be sumoylated regardless of cell density C, Merlin S518D is strongly sumoylated at both high and low cell densities. 
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Introduction
The NF2 tumor suppressor protein merlin is structurally related to the protein 4.1 family of molecules and, specifically, a subgroup including ezrin, radixin, and moesin (ERM proteins). Like the ERM proteins, merlin contains an NH 2 terminal domain (NTD; residues 1-302), which is highly conserved among all members of the protein 4.1 family and is thought to mediate interactions with the cytoplasmic tail of cell surface glycoproteins, such as glycophorin C and CD44 (1) . The second half of the molecule contains a predicted a-helical domain (residues 303-478) and a unique COOH terminal domain (CTD; residues 479-595). ERM proteins link the actin cytoskeleton to cell surface glycoproteins. Merlin can associate with polymerized actin in vitro by virtue of an amino (NH 2 ) terminal actin binding domain, including residues 178 to 367. Merlin actin binding is not affected by natural NF2 patient mutations or alternatively spliced isoforms (2) . Phosphatidylinositol lipids have been implicated in ERM protein activation. For example, PI(4,5)P 2 enhances the ability of full-length radixin, but not its NTD, to bind the cytoplasmic tail of CD44. However, the tail of CD44 does not bind PI(4,5)P 2 , suggestive of an activating effect on full-length radixin (3). Analysis of recombinant moesin T588D, which mimics phosphorylated moesin, suggests an auxiliary role for PI(4,5)P 2 in unmasking the COOH terminal filamentous actin (F-actin) binding site. Recent work using either unphosphorylated or T558-phosphorylated moesin purified from platelets revealed a dual requirement for T558 phosphorylation and the presence of a detergent and a phospholipid, such as PI(4,5)P 2 , for F-actin binding (4) . In support of a two-step activation process wherein PI(4,5)P 2 renders moesin susceptible to COOH terminal phosphorylation, transfection studies have suggested that enhanced phosphatidylinositol 4-phosphate 5-kinase activity results in enhanced phosphorylation of the COOH terminal threonine (5).
Merlin is phosphorylated on both serine and threonine residues, and the phosphorylation status of merlin varies in response to growth conditions (6) . PAK2 phosphorylates S518 and abolishes merlin NH 2 /COOH terminal binding. PAK2 also impairs the ability of merlin to bind to two interacting proteins, CD44 and HRS, both critical for merlin growth suppression (7) . In addition to the phosphorylation of S518, PKA has recently been shown to phosphorylate S10 and affect the actin cytoskeleton, mediating cell migration (8) . Most recently, we show that Akt phosphorylates merlin on residues T230 and S315, which abolishes merlin intramolecular NTD/CTD interaction and merlin binding to PIKE-L and other binding partners, leading to merlin degradation by polyubiquitination (9) . Phosphorylation and PI(4,5)P 2 binding coordinately mediate the activation of ERM proteins (5, 10) . However, whether the dual regulatory machinery also controls merlin activity remains elusive. In this report, we show that the NTD of merlin associates directly with phosphatidylinositols, for which the ''open'' conformation is required. Moreover, Akt phosphorylation enhances the interaction between merlin and phosphatidylinositols. Akt phosphorylation blocks its proapoptotic activity. Finally, we show that Akt phosphorylation of merlin substantially inhibits its proapoptotic activity and blocks its tumorsuppressive activity on cell migration.
Materials and Methods
Cells and reagents. Both 5 4 and 6 7 , which are RT4-D6P2T schwannoma cells stably transfected with wild-type merlin (merlin T230DS315D and T230AS315A stably expressed cells), were maintained in DMEM including 10% fetal bovine serum, 100 units of penicillin-streptomycin, 500 Ag/mL of G-418, and 1 Ag/mL of puromycin. L64P, S518A, and S518D cells are patientderived mutant (L64P), and S518 phosphorylation mutant stably transfected RT4-D6P2T cells. Merlin proteins were induced by 1 Ag/mL of doxycycline treatment and then incubated for 24 h. HCT116 and HCT116 PTEN À/À cells Research Article were maintained in McCoy's 5A, including 10% fetal bovine serum and 100 units of penicillin-streptomycin. All cells were maintained at 37jC with 5% CO 2 atmosphere in a humidified incubator. Wortmannin, LY294002, and glutathione S-transferase (GST)-horseradish peroxidase were from Sigma. Akt1/2 inhibitor was from VWR, and PAK inhibitor IPA-3 was from Sigma. Phosphatidylinositol-conjugated beads and various phosphatidylinositols diC16 were from Echelon, Inc. Cosedimentation of merlin recombinant proteins with lipid vesicles. The analysis of merlin-lipid interactions by cosedimentation of proteins with multilamellar liposomes was performed as described (11) . Multilamellar liposomes were prepared from phosphatidylcholine and PI(3,4,5)P 3 , PI(4,5)P 2 , PI(3,4)P 2 , and phosphatidylinositol in a buffer containing 20 mmol/L of HEPES (pH 7.4) and 0.2 mmol/L of EGTA. Proteins were subsequently incubated for 15 min at 25jC in the presence of 130 mmol/L of KCl and in the absence of liposomes, followed by further incubation in the absence or presence of liposomes for 15 min. The mixtures were subsequently centrifuged for 30 min at 100,000 Â g at 4jC. The pellets were solubilized in 50 to 100 AL sample buffer. After SDS-PAGE, the amount of protein present in pellets and supernatants was quantified by scanning the bands of the Coomassie blue-stained gels. The amount of merlin sedimented in the absence of liposomes was subtracted from that sedimenting in the presence of lipid.
In vitro binding assay between GST-CD44 CTD and merlin in the presence of lipid micelles. The glutathione beads binding to GST-CD44 CTD or GST alone were pretreated with radioimmunoprecipitation assay buffer [0.1% SDS, 0.5% deoxycholic acid, 1% NP40, 50 mmol/L Tris-HCl (pH 8.0), and 150 mmol/L NaCl] for 20 min at room temperature. They were washed with 20 vol of buffer containing 10 mmol/L of HEPES (pH 7.5), 1 mmol/L of MgCl 2 , and 40 mmol/L of NaCl. After brief centrifugation, the beads were resuspended in 130 AL of buffer containing 50 Ag/mL of phosphatidylserine and a variety of 5 Ag/mL phosphatidylinositols. The mixture was sonicated, and the resulting vesicles were mixed with the glutathione beads and 2.6 Ag of purified merlin. The reaction mixture was incubated at room temperature with constant rotation, followed by immunoblotting.
Wound-healing assays. RT4 schwannoma cells were stably transfected with inducible T230DS315D and T230AS315A mutant constructs. Three independent clones for each mutant were used for the migration assay. The cells were induced by doxycycline and split into 10-cm dishes and incubated until 90% to 100% confluent. After dishes were scratched by blue tip (0 h), cells were incubated for different time courses. The pictures were taken at 0, 6, 12, and 18 h, respectively. Phase contrast images were taken by Olympus IX71. Measurement of the wound-healing gap distance was performed using the computer program Image J. Results were expressed as mean F SE. P V 0.05 was considered significant (Student's t test).
Results
The NH 2 terminus of merlin binds phosphatidylinositols. To examine whether phosphatidylinositol lipids are involved in binding to merlin, we performed in vitro binding assays. PI(3,4,5)P 3 selectively interacted with both NTD and full-length merlin, but not CTD or negative control GST. By contrast, PI(4,5)P 2 weakly associated with both NTD and CTD, but not full-length merlin (Fig. 1A) . Truncation assay showed the extreme NH 2 terminal 1-82 and 1-132 fragments associated with PI(3,4,5)P 3 ; in contrast, all the other truncates lacking the NH 2 terminal 1-132 region failed to bind PI(3,4,5)P 3 ( Fig. 1B, top) .
As a measure for bilayer association, cosedimentation of proteins with liposomes containing 20% of a variety of phosphatidylinositol lipids and 80% phosphatidylcholine was analyzed. Control values of protein sedimenting in the absence of lipids were subtracted. Lipid interactions were measured under physiologic ionic strength conditions, as described in Materials and Methods. GST-merlin NTD strongly cosedimented with PI(3,4,5)P 3 liposomes (25 F 5%). It revealed comparable affinity to both PI(4,5)P 2 and PI(3,4)P 2 with 18 F 4% and 20 F 3%, respectively. However, its affinity to PI(3)P was substantially decreased to 6 F 2%. By contrast, GST-merlin CTD almost did not bind to 3 ¶-phosphorylated phosphatidylinositol lipids, but it potently cosedimented with PI(4,5)P 2 (26 F 6%). GST alone revealed negligible cosedimentation activity to all liposomes (Fig. 1C) . Therefore, these findings support that merlin NTD possesses much stronger PI(3,4,5)P 3 binding affinity than its CTD, which, instead, reveals tighter affinity to PI(4,5)P 2 . The unfolded conformation is required for the association between merlin and phosphatidylinositols. The NH 2 terminus of ezrin reveals more potent binding activity to PI(4,5)P 2 than fulllength ezrin in the presence of physiologic ionic conditions, suggesting that folding conformation mediates its binding affinity to phosphatidylinositol lipids (11) . To explore whether merlin folding conformation mediates its binding effect to phosphatidylinositol lipids, we used three forms of well-characterized merlin mutants: L64P, S518D, and S518A. The patient-derived L64P mutant displays an open inactive conformation, and so does S518D. However, S518A possesses a folded active conformation. We examined the binding activity in RT4-D6P2T schwannoma cell lines stably transfected with inducible wild-type and mutated merlins. The parental RT4-D6P2T schwannoma cell line expresses a negligible amount of merlin (7) . Interestingly, no binding activity was observed with S518A. Surprisingly, S518D robustly associated with phosphatidylinositol lipids (Fig. 2, left, second row) . Both wildtype and L64P merlin interacted with PI(4,5)P 2 , PI(3,4)P 2 , and PI(3,4,5)P 3 . However, wild-type merlin in 5 4 cells displayed the strongest binding activity to PI(4,5)P 2 . By contrast, L64P revealed the most prominent interaction with PI(3,4,5)P 3 . These observations strongly support the notion that PI(3,4,5)P 3 or PI(3,4)P 2 robustly bind to open merlin whereas PI(4,5)P 2 preferentially interacts with native merlin.
Akt phosphorylation of merlin increases its affinity to phosphatidylinositols. To explore whether Akt phosphorylation of merlin mediates its binding activity to phosphatidylinositols, we conducted an in vitro binding assay. Under control conditions, the NTD strongly bound to PI(3,4,5)P 3 , whereas full-length merlin barely associated with PI(3,4,5)P 3 . In the presence of active Akt, both the NTD and full-length merlin displayed substantially elevated binding affinities to PI(3,4,5)P 3 (Fig. 3A) . To examine the effect of Akt phosphorylation on merlin's binding behavior to phosphatidylinositols in intact cells, we infected 5 4 schwannoma cells with adenovirus expressing plasma membrane-localized active myristoylated Akt and short hairpin RNA of Akt1. Under control conditions (Fig. 3B, bottom left) , wild-type merlin exhibited a binding effect to various phosphatidylinositols, with the strongest activity to PI(4,5)P 2 , a phenomena similar to what was observed in Fig. 2A . However, when Akt1 was depleted, merlin lost its binding activity to both PI(3,4)P 2 and PI(3,4,5)P 3 , but it still retained affinity to PI(4,5)P 2 , indicating that Akt phosphorylation is not required for merlin to bind to PI(4,5)P 2 ( Fig. 3B, middle left) . In the presence of active Akt, merlin displayed obviously increased binding effect to both PI(3,4,5)P 3 and PI(3,4)P 2 , whereas merlin remained comparable affinity to PI(4,5)P 2 as the control condition (Fig. 3B, top left) , supporting that Akt phosphorylation provokes merlin binding to 3 ¶-phosphorylated phosphatidylinositols. Both GSK3h and merlin S315 phosphorylation tightly correlated with Akt1 expression and activation profiles (Fig. 3B, right) . Compared with wild-type NTD, purified recombinant GST-merlin 1-332 (T230DS315D) revealed much stronger binding activity to PI(3,4,5)P 3 (Fig. 3C) . We have made similar observations with mammalian cells transfected with green fluorescent protein (GFP)-merlin. The phosphorylation mimetic merlin (T230DS315D) displayed markedly higher affinity to both PI(4,5)P 2 and PI(3,4,5)P 3 than wild-type merlin. By contrast, unphosphorylated merlin (T230AS315A) failed to bind either lipid (Fig. 3D) , similar with S518A. These data further support that Akt phosphorylation is indispensable for merlin to interact with PI(3,4,5)P 3 . Thus, Akt plays a critical role in dictating the binding of merlin to phosphatidylinositols.
PI(3,4,5)P 3 lipid enhances merlin binding affinity to CD44. To explore whether phosphatidylinositols regulate the interaction between merlin and CD44, we conducted an in vitro binding assay in the presence of phosphatidylserine or PIPx/phosphatidylserine micelles. Under the control condition (50 Ag/mL phosphatidylserine), GST-CD44 CTD, but not GST, selectively interacted with merlin (Fig. 4A, lanes 9 and 10) . Phosphatidylinositol did not significantly elevate the interaction between merlin and CD44 CTD, whereas PI(3,4)P 2 and PI(4,5)P 2 notably augmented the association (Fig. 4A) . Remarkably, PI(3,4,5)P 3 elicited the strongest binding affinity between CD44 CTD and merlin (lane 8), indicating that (5 4 ), L64P, and S518 phosphorylation mutants. After merlin induction by doxycycline, the cell lysates (1 mg) were incubated with 30 AL of PI(4,5)P 2 -conjugated, PI(3,4)P 2 -conjugated, or PI(3,4,5)P 3 -conjugated beads, and then proteins were separated by SDS-PAGE and analyzed by Western blotting (left). Equal amounts of cell lysates were used in the binding assay (right ).
PI3K Signaling Regulates Merlin Biological Activities
www.aacrjournals.org phosphatidylinositol 3-kinase (PI3K) might up-regulate the merlin-CD44 association.
Inactivating mutations of PTEN tumor suppressor gene are found in a wide range of human cancers. PTEN is a lipid phosphatase that converts the second messenger PI(3,4,5)P 3 to PI(3,4)P 2 (12) . To further test whether PI(3,4,5)P 3 mediates the interaction between CD44 and merlin in intact cells, we used the PTEN knockout HCT116 colon cell line, a previously described isogenic set of HCT116 cells in which PTEN genes had been deleted (13) . We cultured the wild-type and PTEN-deleted cells at high density (100% confluence) and low density (50% confluence) and then immunoprecipitated merlin. The CD44-merlin association was substantially enhanced at the low-density culture compared with the high-density culture in wild-type HCT116 cells. Interestingly, significantly more CD44 was coprecipitated with merlin in highly confluent PTEN-null HCT116 cells than in the low-density cells (Fig. 4B, left) . Akt phosphorylation was augmented in lowdensity HCT116 cells compared with high-density cells. As expected, Akt was highly phosphorylated in PTEN-null cells whether the cells were confluent or not. Accordingly, merlin S315 phosphorylation tightly correlated with Akt activation pattern (Fig. 4B, right) . These data suggest that Akt phosphorylation and PI(3,4,5)P 3 lipid regulate the association between CD44 and merlin.
Because PTEN antagonizes PI3K signaling by hydrolyzing PI(3,4,5)P 3 back into PI(4,5)P 2 , we wondered whether the elevated concentrations of PI(3,4,5)P 3 and hyperactive Akt in PTEN knockout cells would affect merlin's subcellular distribution. In wild-type HCT116 cells, endogenous merlin mainly localized in the cytoplasm and the cell-cell contact region. Epidermal growth factor (EGF) treatment relocalized merlin to the whole cytoplasm, and the concentration in the cell-cell contact was significantly decreased (Fig. 4C ). This effect was substantially blocked by PI3K inhibitor wortmannin pretreatment (data not shown), indicating that Akt phosphorylation and PI(3,4,5)P 3 binding might contribute to the redistribution of merlin in the cytoplasm. However, in HCT116 PTEN-null cells, endogenous merlin was distributed in the whole cells, resembling the patterns observed in EGF-treated wildtype cells. It is worth noting that merlin was highly enriched in the microvilli and small protrusions (Fig. 4D, top, white arrows) . By contrast, the actin filament was enriched in the cell boundaries. Strikingly, EGF provoked a tremendous number of small protrusions on the plasma membrane, where merlin and F-actin were aggregated and colocalized (Fig. 4D, bottom, white arrows) . These results support that PI(3,4,5)P 3 binding and Akt phosphorylation synergistically facilitates merlin relocation and regulates its cellular effect on F-actin organization. Immunostaining with anti-phosphorylated S315 antibody revealed similar results (data not shown).
Akt phosphorylation of merlin inhibits its proapoptotic activity. Transduction of merlin into human schwannoma cells decreases cell proliferation by inducing apoptosis (14) . In Drosophila, merlin and expanded, similar to other components of the hippo pathway, are required for proliferation arrest and apoptosis in developing imaginal discs (15) . Thus, merlin is somehow implicated in triggering apoptosis. To explore whether 
www.aacrjournals.org the Akt phosphorylation of merlin mediates its proapoptotic effect, we cotransfected a variety of GFP-tagged merlin constructs into HEK293 cells with constitutively active Akt (Akt-CA) or kinase-dead Akt (Akt-KD) and monitored cell apoptosis. Compared with controls, overexpression of wild-type merlin provoked significant apoptosis, which was further elevated by unphosphorylated mutants (T230AS315A). By contrast, apoptosis was substantially decreased with the mutant (T230DS315D). Cotransfection of active Akt with wild-type merlin markedly diminished its proapoptotic actions. The apoptotic activity was recovered when merlin was cotransfected with Akt-KD (Fig. 5A) . We also monitored cell death with trypan blue assay (Fig. 5B) . Poly(ADP-ribose) polymerase (PARP) cleavage and caspase-3 activation were in alignment with the quantitative apoptotic results (Fig. 5C ), underscoring that merlin phosphorylation by Akt is required to block its proapoptotic action.
The extreme NH 2 terminus of merlin is implicated in binding phosphatidylinositol lipids. It remains unknown whether this interaction is implicated in the proapoptotic action of merlin.
Wild-type merlin and phosphorylated/mutated merlin, such as S518A and S518D, display different binding affinities to PI(3,4,5)P 3 and two different PIP 2 . To address whether lipid binding by merlin plays any role in mediating its proapoptotic action, we monitored cell survival activity. When merlin is in open conformation, like S518D, the proapoptotic action of merlin was substantially diminished as in T230DS315D transfected cells; in contrast, when merlin is in close conformation, like S518A, it displayed more potent apoptotic action than wild-type merlin. Interestingly, truncation of the 1-133 region in merlin had no effect on merlin's proapoptotic action (Fig. 5D) . PARP cleavage and caspase-3 activation correlated with apoptosis results (data not shown). Hence, PIP2 or PI(3,4,5)P 3 binding is not essential for the proapoptotic activity of merlin.
Merlin phosphorylation by Akt affects its subcellular distribution and cell migration. To explore whether Akt phosphorylation alone regulates merlin's subcellular residency, we transfected HEK293 cells with Myc-merlin constructs. T230DS315D mainly accumulated in the small protrusion structures on the ruffled membrane, long cell extension, and cytoplasm in most of the transfected cells. Actin filaments strongly colocalized with merlin T230DS315D in the long cell extension (white arrow). In contrast, merlin mutants (T230AS315A) predominantly resided on the smooth plasma membrane without the aggregation in the protrusion (Fig. 6A) . EGF also provoked Myc-merlin accumulation in the ruffled membrane, which was blocked by wortmannin (Fig. 6B, top) , underscoring that Akt phosphorylation of merlin dictates its subcellular distribution. Immunostaining with antiphosphorylated merlin S315 confirmed the observation (Fig. 6B,  middle) . To further test the notion that Akt phosphorylation regulates merlin aggregation in the ruffled plasma membrane, we cotransfected GFP-merlin into HEK293 cells with constitutive active Akt-CA and Akt-KD. GFP-merlin was strongly phosphorylated by Akt-CA, but not by Akt-KD, and accumulated on the disheveled plasma membrane (Fig. 6C) . We made a similar observation in GFP-merlin and RFP-Akt cotransfected cells (Supplementary Fig. S1 ). Therefore, Akt phosphorylation plays an essential role in regulating merlin's subcellular distribution.
To explore whether Akt phosphorylation regulates the effect of merlin in cell motility, we conducted a wound-healing assay with RT4 schwannoma cells. The stable clones were transfected with inducible T230DS315D and T230AS315A mutants. Both cell lines transfected with wild-type merlin (5 4 and 6 7 ) loosely filled the wound. However, T230DS315D cells migrated faster and completely sealed the gap. Nevertheless, T230AS315A cells moved much slower than wild-type controls, and only about half of the gap was filled (Fig. 6D, left) . These data support that Akt phosphorylation of merlin plays a critical role in mediating its effect on cell migration, fitting with our previous observation in Matrigel Boyden chamber (9) .
Both Akt and PAK are implicated in phosphorylating merlin and regulate its binding to phosphatidylinositol lipids, but it remains unknown which signaling is essential for dictating the effect of merlin in cell migration. To quantitatively analyze this effect, we conducted a time course cell migration assay. In Supplementary  Fig. S2 , we show that merlin S518D cells migrated much faster than 5 4 cells. Blocking Akt by Akt1/2 or wortmannin inhibitor largely diminished both wild-type 5 4 and S518D cell migration; by contrast, inhibiting PAK3 markedly decreased wild-type, but not S518D, cell migration. This finding suggests that PI3K/Akt signaling is critical for schwannoma cell migration, for which merlin phosphorylation by Akt might be critical. On the other hand, S518 phosphorylation by PAK is also implicated in this event. Compared with merlin lacking V 1 schwannoma control cells, induction of wild-type merlin markedly decreased cell migration in 5 4 cells in a time-dependent manner. Notably, induction of S518A further inhibited cell migration. As expected, phosphorylation of S518 significantly abolished the inhibitory effect of merlin in cell migration, as the migratory speed was substantially increased in S518D cells (Fig. 6D,  right) .
Discussion
In this report, we show that merlin directly binds phosphatidylinositols, and this action is mediated by merlin folding conformation and Akt phosphorylation. Wild-type merlin reveals a stronger affinity to PI(4,5)P 2 than PI(3,4,5)P 3 , whereas the patientderived L64P, which possesses an unfolded conformation, exhibits a more potent affinity to PI(3,4,5)P 3 than PI(4,5)P 2 . This observation was further supported by the finding with S518D, which also displays an open structure. By contrast, the folded S518A mutant fails to bind any of the phosphatidylinositols, underscoring that the open inactive conformation is required for merlin to bind PI(3,4,5)P 3 . Moreover, we found that the interaction between merlin and PI(3,4,5)P 3 was evidently enhanced by Akt phosphorylation. Nevertheless, Akt phosphorylation is dispensable for merlin to associate with PI(4,5)P 2 . Although binding to phosphatidylinositol lipids require merlin to maintain an inactive status, the functional relevance of this interaction remains obscure. Truncation of the 1-133 region in the NH 2 terminus, which is implicated in binding to PI(3,4,5)P 3 , does not alter the proapoptotic action of merlin (Fig. 5D) , suggesting that phosphatidylinositol binding to merlin is dispensable for this effect.
Previously, it has been reported that hypophosphorylated merlin, but not ezrin or moesin, binds the cytoplasmic tail of CD44 at high cell densities. At low cell densities, ezrin, moesin, and the phosphorylated form of merlin are associated with CD44, and this CD44-merlin association is likely to be indirect through ERM proteins (16) . Consistently, we observed the increased interaction between CD44 and merlin in low-density HCT116 cells compared with high-density cells. Strikingly, the strongest CD44-merlin association occurred in high-density PTEN-null cells, which was slightly decreased when cell density was reduced (Fig. 5B) . It remains unclear why, in PTEN-null cells, the association between CD44 and merlin was attenuated in low density compared with high density. Although the PI3K/Akt signaling cascade is markedly increased, when PTEN is depleted, other cell signalings that are dictated by cell/cell contact remain intact in PTEN-null cells. For instance, contact inhibition can be triggered by the addition of cell membrane preparations to dividing cells in vitro (17, 18) . Adhesion molecules, including particular cadherins and integrins, induce cell cycle arrest upon contact with specific components of the extracellular matrix or with neighboring cells (19, 20) . Presumably, these mechanisms operate in concert or in hierarchy to mediate cellular responses to contact with extracellular matrix and with other cells in addition to PI3K/Akt. This notion is indirectly supported by the cell migration observation that PI3K inhibitor wortmannin and Akt inhibitor Akt1/2 slightly but significantly decreased HCT116-PTEN cell migration; by contrast, PAK inhibitor exhibited a negligible effect (Supplementary Table S1 ). The weak inhibitory effect by Akt inhibitors might be due to the hyperactivity of Akt in PTEN-null cells.
To address the functional consequences of the enhanced binding affinity by Akt-phosphorylated merlin to CD44, we knocked down CD44 with its small interfering RNA in T230DS315D stably transfected cells, but we failed to observe any significant effect on cell migration compared with control small interfering RNA (data not shown). This finding indicates that the increased interaction between CD44 and Akt-phosphorylated merlin is not implicated in cell migration. This result is consistent with the previous finding that CD44 is not required for hyaluronan-induced vascular smooth muscle cell migration, which is dependent on PI3K-mediated Rac activation (21) . PI(4,5)P 2 strongly binds full-length wild-type merlin from schwannoma 5 4 cells (Fig. 3) , although it fails to interact with the purified recombinant full-length merlin (Fig. 1A) . This discrepancy might result from posttranslational modification of merlin in 5 4 cells. For example, phosphorylation of merlin might alter its folding conformation, unveiling the binding motif for PI(4,5)P 2 lipid. Unlike other ERM proteins, both the NTD and CTD of merlin bind to PI(4,5)P 2 ; however, PI(3,4,5)P 3 selectively associates with the NTD PI3K Signaling Regulates Merlin Biological Activities www.aacrjournals.org of merlin. Under subconfluent conditions, a portion of merlin might be phosphorylated by PAK on S518 in the CTD, leading to an unfolded conformation of merlin. PI(4,5)P 2 binds merlin and docks it to the plasma membrane. When growth factors are introduced, Akt is immediately activated and translocated to the plasma membrane, wherein its PH domain binds to newly generated PI(3,4,5)P 3 by PI3K, and the active Akt then attacks the NTD of merlin and phosphorylates it, resulting in a fully opened Figure 6 . Merlin phosphorylation by Akt regulates its subcellular distribution and cell migration. A, Akt phosphorylation of mimetic mutant T230DS315D aggregated in the ruffled plasma membrane and relocated in the cytoplasm. HEK293 cells were transfected with T230AS315A and T230DS315D constructs, respectively. The transfected cells were stained with rhodamine-phalloidin. T230DS315D colocalized with F-actin in long cell extension (arrow). It was also distributed in the cytoplasm. B, EGF treatment provoked S315-phosphorylated merlin to accumulate on the disheveled plasma membrane. C, Akt-CA, but not Akt-KD, promoted merlin S315 phosphorylation and aggregation on the plasma membrane. D, wound-healing assay. RT-4 schwannoma cells stably transfected with inducible merlin wild-type (5 4 or 6 7 ), T230AS315A, or T230DS315D mutants were split in a 10-cm dish. Three independent clones for each mutant were used for the migration assay. One representative photo from three clones was presented (left). Quantitative analysis of the effect of merlin S518 phosphorylation in cell migration. Induction of wild-type merlin in 5 4 cells elicited a time-dependent inhibitory effect in cell migration (right ). Columns, mean; bars, SE (*, P V 0.01; #, P < 0.05, Student's t test).
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Cancer Res 2009; 69: (9) . May 1, 2009 conformation. PI(3,4,5)P 3 subsequently tightly binds to the NTD, which in turn, further enhances its phosphorylation by Akt and many other kinases, including PKA, PAK, etc., leading to the full inactivation of merlin.
Merlin directly associates with PIKE-L GTPase that binds PI3K and enhances its kinase activity (22, 23) . Merlin exerts its growthinhibitory effect, at least in part, by inhibiting PI3K/Akt signaling. This suppressive activity was achieved by blocking the stimulatory effect of PIKE-L on PI3K (23) . Recently, we showed that Akt feeds back and robustly phosphorylates merlin on both T230 and S315 residues and unfolds merlin, leading to its polyubiquitination and degradation. Although either Akt or PAK phosphorylating merlin results in its binding to phosphatidylinositol lipids, merlin S518 phosphorylation by PAK cannot provoke merlin polyubiquitination and degradation (9) . This finding suggests the unique aspect of the regulatory role of Akt in mediating merlin tumor suppressor. Nonetheless, it remains unclear whether phosphatidylinositol binding plays any role in triggering merlin degradation or plasma membrane residency. Here, we provide biochemical evidence revealing that PI(3,4,5)P 3 , an essential second messenger generated by active PI3K, strongly binds Akt-phosphorylated merlin. Conceivably, this phosphatidylinositol lipid binding action might coordinately inactivate merlin with Akt. The dual regulation of merlin by phosphatidylinositol binding and Akt phosphorylation provides a novel mechanism explaining how the oncogenic PI3K signaling crosstalks with the tumor suppressor merlin.
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No potential conflicts of interest were disclosed. l e t t e r s Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation Analysis of the merlin protein sequence revealed that amino acids 225-231 (RNKKGTE) and 310-316 (RRKADSL) correspond to consensus Akt phosphorylation motifs previously identified in numerous Akt substrates. Using an in vitro kinase assay, we showed that both full-length merlin and its NTD only were robustly phosphorylated by active Akt. By contrast, other AGC kinase family members (the family that Akt belongs to), including p70 S6K and p90 RSK , failed to phosphorylate merlin, indicating that Akt specifically phosphorylates merlin (Fig. 1a) . Neither rapamycin (which inhibits the kinase mTOR) nor rapamycin in combination with PD98059 (a MAP-kinase kinase (MEK1) inhibitor) attenuated Akt S473 and merlin S315 phosphorylation, although they completely blocked p70 S6K phosphorylation, consistent with our in vitro kinase results that showed that p70 S6K failed to phosphorylate merlin (Supplemental Fig. S1 ).
To define the Akt-phosphorylated residues in merlin, we showed that the NTD (1-332) fragment was strongly phosphorylated, whereas the fragments 1-232 and 1-282 were only weakly phosphorylated. No phosphorylation was detected in other fragments (Fig. 1b, top panel) , indicating that amino acids RNKKGTE (225-231) and RRKADSL (310-316) are the likely Akt phosphorylation sites. Phosphorylation of merlin containing either a T230A or S315A mutation was lower than with wild-type NTD, and was completely abolished in T230A/S315A double mutants, indicating that both the T230 and S315 residues are merlin Akt phosphorylation sites (Fig. 1c) . Metabolic labelling with [ 32 P] H 3 PO 4 reveals that phosphatidylinositol-3-OH kinase (PI(3)K inhibitors), but not a MEK1 inhibitor, significantly reduced merlin phosphorylation (Fig. 1d, top left  panel) . The T230A mutant had decreased merlin phosphorylation, and significantly lower phosphorylation took place in the S315A mutant. Moreover, epidermal growth factor (EGF)-induced phosphorylation was not detected in the T230A/S315A merlin mutant, demonstrating that both T230 and S315 are major phosphorylation sites. Furthermore, neither rapamycin nor rapamycin in combination with PD98059 decreased EGF-provoked merlin phosphorylation, indicating that other AGC family kinases are not implicated in phosphorylating merlin.
To determine whether merlin S315 was phosphorylated in vivo, we generated a merlin antibody that specifically recognized phosphor-S315. The immunoreactivity of this antibody was blocked by a phosphopeptide antigen, but not by non-phosphopeptide (Fig. 1d, right panels) , confirming the specificity of the antibody. Immunoblotting with this antibody correlated with the metabolic labelling results (Fig. 1d, left,  second panel) . S315 was phosphorylated in wild-type merlin, and this phosphorylation was abrogated in the S315A mutant (Fig. 1e) . Similarly, active Akt strongly stimulated merlin phosphorylation, whereas depletion of Akt abolished merlin phosphorylation (Fig. 1f) . The reduction of merlin S315 phosphorylation in the T230A mutant under both serumstarvation and EGF-stimulation conditions suggests that T230 somehow affects S315 phosphorylation. Thus, T230/S315 phosphorylation is hierarchal (Fig. 1g) . Taken together, our data support the idea that merlin is a physiological substrate of Akt in mammalian cells. Fig. S4 for a bigger image) . Phosphopeptide antigen, but not the non-phosphopeptide, blocked merlin S315 phosphorylation (right lower panel). Merlin S315 and Akt phosphorylation and merlin expression were verified (left second to bottom panels). (e) EGF triggers merlin wild type but not S315A phosphorylation in intact cells. EGF enhanced S315 phosphorylation in wild-type merlin, which was abolished in S315A mutant transfected cells (top panel) (see Supplementary Fig. S4 for a bigger image). (f) Akt phosphorylates merlin in mammalian cells. Akt and merlin protein levels in cell lysates were confirmed (top and second panels). Positive control GSK-3 and merlin S315 phosphorylation were verified (third and bottom panels). (g) T230 affects S315 phosphorylation in merlin. WT, wild type. l e t t e r s GST pulldown assays revealed that both the NTD and the CTD fragements of merlin I (contains 1-595 residues) robustly associated with Akt, whereas the CTD of merlin II (contains 1-590 residues) had a low level of binding to Akt. Interestingly, neither full-length merlin I nor merlin II interacted with Akt (Fig. 2a, top panel) . Because merlin I forms an intramolecular complex requiring NTD/CTD binding 1 , we sought to determine whether EGF mediates the interaction between merlin and Akt. We employed the RT4-D6P2T rat schwannoma cells with doxycycline-controllable expression of either wild-type (WT; 5 4 and 6 7 ) or patient-derived (L64P) mutant merlin 6, 10 . In the absence of EGF, endogenous Akt associated with L64P, which does not form a productive intramolecular complex, whereas negligible binding was observed with wild-type merlin. By contrast, EGF stimulated a robust interaction between wild-type merlin and Akt in both merlin-inducible (5 4 and 6 7 ) cell lines with an affinity similar to that of the L64P mutant, indicating that EGF facilitates merlin-Akt association, probably by activating Akt, which leads to merlin unfolding following Akt-mediated phosphorylation (Fig. 2b, top panel) . Wild-type merlin phosphorylation status correlated with its association with Akt (Fig. 2b, bottom panel) . Surprisingly, L64P was barely phosphorylated, although it abnormally interacted with Akt regardless of EGF stimulation. EGF-induced Akt-merlin complex formation was disrupted by PI(3)K inhibitors, but was not affected by an MEK inhibitor or PKC (protein kinase C) inhibitor (GF109203X), again suggesting that Akt activation is required for Akt-merlin association (Fig. 2c, top panel) . In addition, merlin S315 phosphorylation status on the precipitated beads tightly correlated with its interaction with Akt (Fig. 2c, second panel) . Interestingly, merlin S315 phosphorylation in Akt immunoprecipitation is stronger than that in cell lysates. Presumably, other kinases, which are enriched by the Akt antibody during immunoprecipitation, nonselectively provoked Akt-bound merlin phosphorylation. Constitutively active Akt (CA; T308D/S473D) strongly bound to merlin, whereas WT Akt weakly interacted with merlin. A kinase-dead (KD; K179A) Akt mutant failed to associate with merlin, indicating that Akt kinase activity is necessary for its association with merlin (Fig. 2d, top panel) . Consistent with these observations, merlin was robustly phosphorylated by a CA and WT, but not kinase-dead, Akt mutants (Fig. 2d, bottom panel) .
Recent studies have shown that the kinase mTOR and the mTOR-rictor complex (mTORC2) regulates Akt 473 phosphorylation, such that depletion of rictor reduces Akt phosphorylation in some cell lines 11, 12 . Experiments using rictor knockout mice also support the idea that rictor is required for Akt 473 phosphorylation 13, 14 . To further explore the effect of Akt activation on the association between endogenous Akt and merlin, we knocked down rictor and observed that Akt phosphorylation was completely abolished. Consequently, merlin S315 phosphorylation was totally blocked, and the association with Akt was also disrupted (Supplemental Fig. S2 ). Thus, Akt activation and subsequent merlin phosphorylation are essential for endogenous merlin binding to Akt.
Mapping experiments demonstrated that Akt fragments containing either the catalytic domain or the regulatory and at least half of the catalytic domain bound to merlin, whereas the pleckstrin homology (PH) and regulatory domains by themselves did not (Fig. 2e, left, second panel) . These findings suggest that the catalytic domain of Akt is critical for binding to merlin. Presumably, merlin phosphorylation by endogenous Akt triggers its association with the exogenously transfected kinase-deficient Akt fragment #4 (half of the catalytic domain and the tail domain). To test this notion, we conducted a GST pulldown assay with Akt construct fragment #4. The binding of phosphorylation mimetic S315D merlin mutant to Akt fragment was much stronger than that of WT merlin, whereas the nonphosphorylatable S315A mutant failed to bind (Fig. 2e, right panels) . Thus, these data support the idea that merlin phosphorylation is essential for the association.
Cell density regulates merlin phosphorylation and merlin growth-suppressor activity. To determine whether cell density also mediates merlin S315 phosphorylation, we analysed merlin S315 and Akt S473 phosphorylation in NIH3T3 cells at different cell densities using phosphospecific antibodies. We found that both Akt and merlin phosphorylation was significantly decreased as cell density increased (Fig. 2f ). This inverse relationship between merlin S315 phosphorylation, Akt activity and cell density suggests that merlin phosphorylation by Akt takes place under physiological conditions. Moreover, the tight association between endogenous merlin and endogenous Akt gradually decreased as the cell density progressively increased (Fig. 2f, fifth panel) . Hence, Akt forms a complex with merlin under physiological conditions, and Akt kinase activity and merlin phosphorylation by Akt are required for this action.
In the absence of Akt, the merlin CTD bound to the NTD, which was blocked in the presence of an active Akt molecule (Fig. 3a, top panel) . The phosphorylation-mimetic GST-NTD-S315D mutant exhibited weaker affinity for merlin CTD than the non-phosphorylatable GST-NTD-S315A mutant did. Akt phosphorylation further decreased the binding to NTD-S315D, whereas it slightly affected the association with NTD-S315A. These observations suggest that Akt phosphorylation of the merlin NTD disrupts merlin NTD/CTD binding. Merlin normally migrates as a doublet containing both hyperphosphorylated and hypophosphorylated protein species. The merlin CTD I (340-595) bound to the hypophosphorylated merlin NTD more avidly than the CTD II (340-595). Merlin NTD/CTD binding was completely blocked by EGF stimulation, and this effect was abolished by wortmannin pretreatment (Fig. 3b, top panel) . Therefore, this observation indicates that Aktinduced phosphorylation is essential for disrupting the intramolecular binding of merlin.
We next examined whether Akt phosphorylation also affected the association of merlin with several interacting proteins, including PIKE-L, CD44 and ezrin. In the absence of Akt phosphorylation, both full-length merlin and merlin NTD strongly interacted with PIKE-L, whereas the merlin CTD did not bind to PIKE-L, which is consistent with our previous findings 15 . By contrast, after Akt phosphorylation, full-length merlin weakly associated with PIKE-L, and the NTD failed to bind PIKE-L, indicating that Akt phosphorylation of residues within the NTD inhibits the association between merlin and PIKE-L (Fig. 3c) . Compared with the untreated cells, EGF blocked CD44-merlin binding, whereas wortmannin increased CD44-merlin binding. PD98059 and GF109203X had no significant effects on CD44-merlin association (Fig. 3d, top panel) . Akt-mediated merlin phosphorylation completely abolished its binding to ezrin as well (Fig. 3e, top panel) . Collectively, these experiments demonstrate that Akt phosphorylation disrupts the ability of merlin to form both intramolecular and intermolecular associations that are important for its tumour-suppressor activity.
Merlin contains an F1 motif, similar to that in the protein FERM. The F1 motif in FERM has a ubiquitin-like structure 16 and facilitates MDM2 degradation and stimulates the ubiquitination and degradation of TRBP, a double-stranded RNA-binding protein 17, 18 . To determine whether the nature cell biology advance online publication nature cell biology advance online publication nature cell biology advance online publication nature cell biology advance online publication Fig. S4 for a larger image) . (d) Akt kinase activity is required for its association with merlin. Akt WT and constitutively active (CA) Akt but not kinase-dead (KD) Akt robustly bound to merlin (top panel) (see Supplementary Fig. S4 for a larger image) . (e) C-terminal regulatory and half catalytic (CAT) domain of Akt binds to merlin. Merlin phosphorylation status dictates its association with the Akt C-terminal regulatory and half catalytic domain. GST-Akt fragment 4 (#4) associated proteins were analysed with anti-merlin and anti-phospho-S315, respectively (right top and second panels) ( Supplementary Fig. S4 for a larger image) . PH, pleckstrin homology domain; Tail, regulatory domain. (f) Cell confluence dictates merlin and Akt phosphorylation and association. The phosphorylation of merlin S315 and Akt S473 decreased with increasing cell confluence (second and third panels). Equal amount of protein was loaded (top and fourth panels). The interaction between endogenous merlin and endogenous Akt in NIH3T3 cells was reversely coupled to cell density (fifth panel). l e t t e r s F1 motif in the merlin NTD is involved in ubiquitin-mediated degradation, we studied merlin degradation in high-grade human glioma cell lines that lack inactivating NF2 mutations. We found that one cell line (U87MG) exhibited high levels of Akt activation and low levels of merlin (Fig. 4a, left panels) . Treatment with a proteasome inhibitor (MG132) alone did not restore merlin expression in U87 cells. Interestingly, merlin S315 phosphorylation in U87MG was readily detectable and robustly enhanced upon MG132 treatment (Fig. 4a, third panels) . A previous nature cell biology advance online publication nature cell biology advance online publication nature cell biology advance online publication nature cell biology advance online publicationl e t t e r s study demonstrates that wortmannin prevents Akt-induced phosphorylation and ubiquitination, increasing protein stability of p53 19 . As expected, wortmannin slightly enhanced merlin expression at 4 h and substantially elevated merlin level at 12 h. The additive effect was obvious with the combination of MG132 and wortmannin. By contrast, the treatment had no effect on the expression of transfected merlin S315A The N terminus of Merlin is necessary for ubiquitination. The merlin fragment containing residues 1-133 was robustly ubiquitinated, whereas merlin fragments containing residues 133-595 and 1-332 fragments were not (upper left panel). The expression of the transfected merlin constructs was verified (lower left panel). T230D/ S315D merlin NTD was robustly ubiquitinated (right panels). (f) MG132 upregulates ubiquitination of the phosphorylation-mimetic merlin mutant T230D/S315D. T230A/S315A merlin was not ubiquitinated. Compared with wild-type merlin, T230D/S315D was strongly ubiquitinated after MG132 treatment.
nature cell biology advance online publication nature cell biology advance online publication nature cell biology advance online publication nature cell biology advance online publication l e t t e r s (Fig. 4a, right panels) . Merlin was maximally ubiquitinated after 10 min in the presence of EGF (Fig. 4b) . By contrast, merlin T230A/S315A was not ubiquitinated (data not shown). Transfection of CA Akt, but not KD Akt, induced evident merlin ubiquitination (Fig. 4c) , indicating that Akt phosphorylation enhances merlin ubiquitination. Co-transfection of merlin with HA-tagged ubiquitin resulted in robust merlin ubiquitination regardless of EGF stimulation; ubiquitination was completely abolished by wortmannin pretreatment, suggesting that PI(3)K/Akt activity is required for merlin ubiquitination (Fig. 4d) . Using a series of merlin truncation mutants, we found that merlin NTD 1-133 residues are necessary for merlin ubiquitination; however, the NTD is not ubiquitinated (Fig. 4e, left panel) . Nevertheless, we found that the NTD containing T230D or S315D was ubiquitinated, and the strongest ubiquitination took place on the T230D/S315D mutant (Fig. 4e,  right panel) , suggesting that merlin phosphorylation by Akt is necessary for its ubiquitination. Further, wild-type merlin was weakly ubiquitinated and the T230D/S315D mutant was strongly ubiquitinated, and ubiquitination of the mutant increased with MG132 treatment. By contrast, no polyubiquitination of the T230A/S315A mutant was detected regardless of MG132 treatment (Fig. 4f) .
To determine the physiological relevance of phosphorylation of merlin on residues T230 and S315, we prepared stable and inducible RT4 rat schwannoma cell lines with nonphosphorylatable (T230A/S315A) and phosphorylation-mimetic (T230D/S315D) merlin mutants. Compared nature cell biology advance online publication nature cell biology advance online publication nature cell biology advance online publication nature cell biology advance online publicationl e t t e r s with control cells (V1), induction of T230A/S315A merlin resulted in reduced cell proliferation and decreased motility. By contrast, the T230D/S315D mutant increased RT4 rat schwannoma cell growth and motility (Fig. 5b, c) . We made similar observations with T230 and S315 single mutants. However, the effects of S315A and S315D mutants were stronger than those of the T230A and T230D mutants ( Supplementary  Fig. 3 ), suggesting that phosphorylation of merlin on both residues T230 and S315 abrogates merlin growth and motility suppression.
To determine whether merlin phosphorylation by Akt mediates merlin's degradation in primary tumours, we performed immunohistochemistry on a panel of human primary nervous-system tumours, including ependymoma (18 samples), schwannoma (18 samples), meningioma (15 samples) and glioblastoma multiformes (GBM; 28 samples). When Akt was activated (strong Akt-P immunoreactivity), total merlin expression was negligible. Conversely, when merlin immunoreactivity was strong, both merlin S315 and Akt S473 phosphorylation were modest. Phospho-S315 staining was completely blocked by the phospho-antigen, indicating that the staining was specific (Fig. 5d ). Approximately 70% of the tumours exhibit one of these two staining patterns. Collectively, these data suggest that Akt phosphorylation-mediated merlin ubiquitination and degradation is also operative in primary tumours.
Akt binds to phosphorylated but not unphosphorylated merlin. It has been shown before that Akt can exist in a stable complex with several of its substrate proteins (for example, Mdm2, TSC2 and EDG-1) and can also interact with many proteins that do not serve as Akt substrates, but rather seem to play a modulatory part in Akt regulation 20 . Here, we provide compelling evidence supporting the idea that merlin is a physiological substrate of Akt, and that it also robustly associates with active Akt in a phosphorylation-dependent manner. This indicates that formation of this complex is tightly regulated by cell-proliferation signals. However, the possibility that merlin could be indirectly regulated by Akt can not be absolutely ruled out. Merlin might also act in a similar way to many other Akt binding partners to mediate Akt kinase activity. Our previous study shows that merlin suppresses PI(3)K/Akt signalling through inhibiting PIKE-L 15 . Presumably, it can directly downregulate Akt activity by physical interactions as well.
Merlin is key growth regulator in numerous cell types, and its activity is regulated by both cell density and phosphorylation events 5, 6, 8, 9, 15 . Whereas previous studies have shown that merlin binding to critical interacting proteins is abrogated by phosphorylation and that mutant forms of merlin can be degraded by a ubiquitin-mediated mechanism 21 , the relationship between phosphorylation and ubiquitination of merlin levels has not been previously established. p21-activating kinase (PAK) or PKA mediates S518 phosphorylation 4, 22 ; however, we found no phosphorylation with the S518D mutant (data not shown), suggesting that Akt, but not PAK or PKA dependent, phosphorylation selectively elicits merlin ubiquitination. Spectrin binds to merlin [23] [24] [25] , and spectrin has been reported to possess ubiquitin-conjugating enzyme (E2) and ubiquitin-ligase (E3) activities 26 . Presumably, Akt-provoked ubiquitination of merlin is mediated through its binding partner, spectrin (also known as fodrin).
In addition to merlin loss in tumours, Akt-mediated merlin degradation provides another dynamic mechanism for controlling merlin expression under physiological conditions. Previous studies on another tumoursuppressor protein, neurofibromin, the protein product of the neurofibromatosis-1 gene, revealed that rapid degradation of neurofibromin was observed after growth-factor stimulation 27 . Similar to our results on merlin, neurofibromin degradation was mediated by the ubiquitin-proteasome pathway. Our observations, coupled with those on neurofibromin, suggest a dynamic relationship between tumour-suppressor protein stability, growth-factor stimulation and phosphorylation.
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Plasmids and reagents. GST-tagged merlin, merlin NTD (residues 1-332) and merlin CTD (residues 342-595) in pGex vector were kindly provided by Vijaya Ramesh (Molecular Neurogenetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA). Mouse monoclonal anti-HA-HRP, anti-Myc-HRP and anti-GST antibodies were from Sigma (St Louis, MO). Mouse monoclonal anti-Ser 473, and anti-Akt antibodies were from Cell Signaling. Rabbit polyclonal anti-merlin antibody was from Santa Cruz Biotechnology (Santa Cruz, CA). Protein A/G-conjugated agarose beads were from Calbiochem (San Diego, CA). Glutathione Sepharose 4B was supplied by Pharmacia Biotech (Piscataway, NJ).Purified active p90 RSK and p70 S6K assay kit were from Upstate Biotechnology (Waltham, MA). All the chemicals not included above were purchased from Sigma. The sense sequence for rictor lentivirus of shRNA is: 5ʹ-CGGGCAGCCTTGAACTGTTTAACTTCCTgTC ATTAAACAGTTCAAGGCTGCTTTTTG-3ʹ. The anti-sense sequence: 5ʹ-AATTCAAAAAGCAGCCTTGAACTGTTTAATG ACAGGAAGTTAAACAGTTCAAGGCTGC-3ʹ.
Cell culture. The rat RT4-D6P2T schwannoma cells were stably transfected with empty vector, merlin (L64P) or wild-type merlin (5 4 , 6 7 clones; gifts from Peter Herrlich, University of Karlsruhe, Karlsruhe, Germany). They were maintained in DMEM, supplemented with 10% fetal bovine serum (FBS), 2 mg ml -1 glutamine, 100 units penicillin-streptomycin, 500 µg ml -1 G-418, 1 µg ml -1 puromycin at 37 ºC with 5% CO 2 atmosphere in a humidified incubator. Protein expression was induced by 1 µg ml -1 doxycycline for 24 h incubation.
P70
S6K and p90 RSK kinase assay. For the p70 S6K kinase assay, we used the S6 kinase kit from Upstate Biotechnology (Temecula, CA), and employed S6 kinase/Rsk2 substrate peptide (KKRNRTLTK) as a substrate. The reaction mixture were incubated in 1× kinase buffer (20 mM MOPS, pH 7.2, 25 mM β-glycerophosphate, 5 mM EGTA, 1 mM dithiothreitol, 1 mM Na 3 VO 4 , 15 mM MgCl 2 ) with 100 µM of ATP, 10 µCi (0.37 MBq) [γ-32 P] ATP. For the p90 RSK kinase assay, we used the long S6 peptide according to the manufacturer's protocol using purified active His-p90 RSK1 (Upstate Biotechnology). As the negative control, the peptide and reaction mixture were incubated in the absence of active protein kinase. The reaction was performed at 30 °C for 30 minutes and analysed on p81 phosphocellulose paper. The phosphorylated proteins were quantified on a liquid scintillation counter.
Coimmunoprecipitation, in vitro binding assay and Akt kinase assay. The experimental procedures for coimmunoprecipitation, in vitro binding assay and Akt kinase assay have been previously described 10, 28 . Akt was immunoprecipitated with agarose beads covalently linked to an anti-Akt antibody.
Ubiquitinated protein pulldown. Polyubiquitin affinity beads, in which the ubiquitin-associated domain of Rad23 was immobilized, and control beads were purchased from Calbiochem-Novabiochem (San Diego, CA). Whole-cell extracts from HEK293 cells were obtained using lysis buffer consisting of 50 mM HEPES (pH 7.5), 5 mM EDTA, 150 mM NaCl, 1% Triton X-100 and complete protease inhibitor (Roche Applied Science, Indianapolis, IN). 1 mg of each whole-cell extract was incubated with 40 µl of beads in lysis buffer for 4 h at 4 °C, with constant mixing. The beads were then washed three times with the same buffer, and the bound proteins were extracted in SDS buffer and analysed by western blotting using anti-NF2 or anti-HA-HRP antibodies.
Cell motility assay. Cell motility was determined in Transwell (Corning, WilkesBarre, Pennsylvania, chambers containing 8 µm membranes. Briefly, the bottom surface of the membrane was coated with Matrigel (Fisher Scientific, Houston, TX) and 10,000 cells, grown for 24 h either in the presence or absence of doxycycline, were seeded on the outside of the chamber and allowed to attach for 1 h. Cells were gently washed and then the Transwell chambers were inverted for 48 h nature cell biology advance online publication nature cell biology advance online publication nature cell biology advance online publication nature cell biology advance online publication 
